Topics

Companies Related to "Maybe Innate" [Most Relevant Company Matches] RSS

19:01 EDT 17th September 2019 | BioPortfolio

Here are the most relevant search results for "Maybe Innate" found in our extensive corporate database of over 50,000 company records.

Showing "Maybe Innate" Companies 1–25 of 54

Relevant

Innate Pharmaceuticals AB

Innate Pharmaceuticals' business concept is to develop bactericidal drugs that meet important medical needs and for which there is a large market. Our business is based on groundbreaking research findings in the fields of innate immunity and microbiology. Innate will work to identify candidate drugs (chemical compounds) using its own technology platforms and then develop these to the preliminary c...


Innate Biologics, LLC

Innate Biologics, LLC is a privately held company targeting, treating and preventing inflammation and is developing a first of its kind recombinant protein platform, which specifically targets intracellular inflammatory signaling pathways. For more information, go to www.InnateBiologics.com.

Innate Immunotherapeutics Limited

Innate Immunotherapeutics Limited is a public unlisted biopharmaceutical company based in Auckland, New Zealand. The company is focused on the development of a new generation of immune response modifiers for potential use in the treatment of MS and other autoimmune diseases, a range of infectious diseases, certain cancers, and as a novel cellular and humor...


Innate Immune, Inc.

Innate Immune, Inc. is a privately held biotechnology company focused on the discovery and development of drugs that modulate the activity of natural killer T cells for the treatment of immune disorders. The Company has licensed an extensive intellectual property portfolio from Stanford University, Dana Farber Cancer Institute and National Institutes of He...

IFM Therapeutics

IFM Therapeutics is a privately held biopharmaceutical company based in Boston, Massachusetts. The company was founded in 2015 by an international group of preeminent scientists and physicians who have spent decades understanding innate immunity and the role it plays in regulating the immune system. IFM’s team has discovered and developed small molecu...

OncoMab™ GmbH

OncoMab™ GmbH's business is the development of human antibodies for the treatment of cancer. The OncoMab™ way is unique because the antibodies are not developed in mice or by genetic engineering, but are isolated directly from cancer patients. The OncoMab™ antibodies are part of the innate natural immunity against malignant cells. This innate immune system functions as the first defence agai...

Innate Therapeutics Limited

Innate Therapeutics Limited is a public unlisted biopharmaceutical company based in Auckland. The company is focused on the development of a new generation of immune response modifiers for potential use in the treatment of MS and other autoimmune diseases, a range of infectious diseases, certain cancers, and as a novel cellular and humoral adjuvant. For fu...

Probably Relevant

Nuo Therapeutics, Inc.

Nuo Therapeutics, Inc. (the "Company" or “Nuo”) is a biomedical company that pioneers leading-edge biodynamic therapies for wound care. The Company's flagship product, Aurix is a biodynamic hematogel that harnesses a patient's innate regenerative abilities for the management of a variety of wounds. For additional information please visit www.nuot.com. ...

Inimex Pharmaceuticals Inc.

Inimex Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to the discovery, development, and commercialization of new medicines based on the selective modulation of the innate immune response. Inimex’ technology platform will yield novel prophylactic and therapeutic agents which will have a significant impact on management of a wide range of disease indications. Inimex...

NantKwest Inc.

NantKwest (Nasdaq:NK) is a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases. NK cells are the body’s first line of defense due to the innate ability of NK cells to rapidly identify ...

Hycult biotechnology

Hycult biotechnology (Hbt) is a leading supplier of antibodies and reagents for research laboratories. Hycult biotechnology specializes in PLUS QUALITY reagents for studies in the following fields:· Innate Immunity (Antimicrobial peptides, TLR, Complement & Collectins)· Endotoxin & other Microbial toxins· Scavenger Receptors, Coagulation· Oxidation, Cell- & Tissue damage· Adhesion Molecules,...

NantKwest

NantKwest (Nasdaq:NK) is a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases. NK cells are the body’s first line of defense due to the innate ability of NK cells to rapidly identify ...

NantKwest, Inc.

NantKwest (Nasdaq:NK) is a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases. NK cells are the body’s first line of defense due to the innate ability of NK cells to rapidly identify ...

Hycult Biotech Inc.

Hycult Biotech is a leader in the fields of immunology and cell biology, we develop, produce and market antibodies, antibody based products and more specifically immunoassays for innate immunity and directly related fields, with an emphasis on complement, neutrophil proteins, TLR, scavenger receptors and acute phase proteins. Furthermore, we have a strong ...

ImmunoBiology Ltd

ImmunoBiology Ltd is a vaccine company developing the next generation of anti-infective vaccines. The portfolio addresses areas of high unmet need, where the risk and consequence of infection are severe. ImmBio has an established product and process patent that enables the transition between an innate and an adaptive immunological response. ImmBio has expe...

Avegant

Avegant is a technology company exploring new ways to recreate how we see by transforming media to capture the innate clarity of natural perception. Glyph, the world’s first vivid reality near-eye display, is Avegant’s flagship product. Developed and patented on Avegant’s Retinal Imaging Technology, the Glyph is a new category of mediawear that let...

Biothera, the Immune Health Company

Biothera is a privately held biotechnology company dedicated to improving immune health. The company is developing pharmaceuticals that engage the innate immune system to fight cancer. Its lead cancer drug Imprime PGG is currently in multiple Phase 2 clinical trials for non-small cell lung and in a Phase 3 for colorectal cancer. (www.biothera.com)

IDM Pharma

IDM is a biopharmaceutical company focused on the development of innovative products that activate the immune system to treat cancer.IDM is currently developing two types of products designed to:• Destroy cancer cells by activating innate immunity• Prevent tumor recurrence by triggering a specific adaptive immune responseOur mission is to provide highly effective treatments that maintain quali...

Telormedix SA

Telormedix (www.telormedix.com), founded in October 2007, is a biopharmaceutical company focused on targeted immunity and modulation of the innate immune system for treating cancer and autoimmune diseases. The Company’s lead product, TMX-101, recently entered a Phase I/II clinical trial for the treatment of Non-Muscle Invasive Bladder Cancer (NMIBC). ...

Rigontec

Rigontec is the leader in RIG-I targeting therapeutics. Utilizing our proprietary RIG-I agonist platform, we harness one of the most essential pathways in the innate immune system to pioneer a novel immuno-oncology treatment approach. Rigontec’s proprietary agonists specifically activate RIG-I, inducing both immediate and long-term anti-tumor immunity...

Synedgen Inc.

Synedgen Inc. is developing a new class of drugs with the ability to suppress inflammation, reduce infection and improve healing in the gastrointestinal tract and pulmonary tree and to reduce damage and inflammation due to chemical, radiological or physical damage using the science of glycomics - the study of complex sugar structure and function. Synedgen ...

Checkmate Pharmaceuticals, Inc.

Checkmate Pharmaceuticals is a research and development company pursuing a novel approach to specifically activating the innate arm of the immune system to recognize and ultimately destroy tumor cells. The company is leveraging their expertise and the vast body of knowledge in the field of CpG oligonucleotides and is validating an approach that will combine ...

Biothera Pharmaceuticals, Inc.

Biothera is a privately held biotechnology company developing Imprime PGG, a clinical stage immunotherapy drug that modulates key immune cells to orchestrate a coordinated immune response to cancer that involves both the innate and adaptive immune system. Proof of concept has been established from single-arm and randomized phase 2 studies in non-small cell...

Neumedicines Inc.

Neumedicines Inc. is developing protein therapeutics that address unmet clinical and societal needs in the fields of oncology, hematology and immunology. The company’s lead product candidate is HemaMax™ (recombinant human interleukin-12, or rHuIL-12), which functions by targeting multiple pathways of hematopoiesis and innate immunity. HemaMaxâ„...

Emmerex

Emmerex is an early stage bio-pharmaceutical company. It aims to bring to market an anti-cancer therapy. The Emmerex therapy arose as a result of several years' biological research. It has already been proven to be safe in patients. The Emmerex therapy utilises the patients' own innate ability to fight cancer. It cuts off nutrient source of the cancer and attacks the tumours directly. The Emmerex ...


More From BioPortfolio on "Maybe Innate"

Quick Search

Corporate Database Quicklinks